Good evening :)

Invesco India Pharma and Healthcare Fund

Growth

EquitySectoral Fund - Pharma & Health Care
Very High RiskPrincipal investment will be at very high risk

Key Offer Details

Opening date
18 Aug 2026
Closing date
01 Sept 2026
Scheme type
Open-Ended
NAV
₹10
Min. invst.
₹1,000
Min. SIP
₹1,000

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Scheme Info

Plan
Direct
Lock in
None
Exit Load
0.50%
0.50% on or before 3M, NIL after 3M
Expense Ratio
0%
Benchmark
BSE Health Care - TRI

Scheme Objective

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

AMC Profile

Invesco is an independent investment management firm based in Atlanta, Georgia. The company has presence in 25 countries worldwide, serves clients from 120, and has a workforce of 8,000 employees globally.

Total AUM
₹ 1,59,223.67 Cr
No. of schemes
43

Manager Profile

Peers

Peers

Peers & Comparison

Comparing 4 mutual funds from 
EquitySectoral Fund - Pharma & Health Care
Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
Nippon India Pharma Fund14.62%19.48%17.74%
ICICI Pru Healthcare Fund-(IDCW-Payout)3.29%14.52%12.82%
SBI Healthcare Opp Fund(IDCW-Payout)23.59%24.93%16.92%
DSP Healthcare Fund(IDCW-Reinv)9.83%12.79%15.13%

Frequently asked questions

Frequently asked questions

  1. Invesco India Pharma and Healthcare Fund is an open-ended Sectoral Fund - Pharma & Health Care scheme launched by Invesco Asset Management Company Pvt Ltd., investing primarily in Equity. It is benchmarked against BSE Health Care - TRI and offered in Direct and Regular plans with Growth and IDCW options.

  2. The NFO of Invesco India Pharma and Healthcare Fund opens for subscription on 18 Aug 2026.

  3. The NFO of Invesco India Pharma and Healthcare Fund closes for subscription on 01 Sep 2026. Applications must be submitted before this date for allotment at the NFO offer price.

  4. The minimum lumpsum investment in Invesco India Pharma and Healthcare Fund is ₹1,000.

  5. The minimum SIP amount for Invesco India Pharma and Healthcare Fund is ₹100 per SIP installment.

  1. Invesco India Pharma and Healthcare Fund is managed by Aditya Khemani, who has 8 years of fund management experience and also manages 5 other schemes at Invesco Asset Management Company Pvt Ltd..

  2. Invesco India Pharma and Healthcare Fund is a new scheme with no performance track record yet, so it should be evaluated on Aditya Khemani's experience, Invesco Asset Management Company Pvt Ltd.'s record on similar schemes, the fund's Equity strategy, and fit with an investor's existing portfolio — not past returns.

  3. Invesco India Pharma and Healthcare Fund is categorized as a Sectoral Fund - Pharma & Health Care scheme under SEBI's mutual fund classification — investing at least 35% each in large-cap and mid-cap stocks (for Large & Mid Cap funds).

  4. Invesco India Pharma and Healthcare Fund has no lock-in period and an exit load of 0.5% if redeemed within 3 months of investment.